IAA
VRTX icon

Independent Advisor Alliance’s Vertex Pharmaceuticals VRTX Stock Holding History

Independent Advisor Alliance’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.46M Sell
2,935
-332
-10% -$147K 0.03% 352
2026
Q1 		$1.46M Sell
3,267
-33
-1% -$15.4K 0.02% 659
2025
Q4 		$1.5M Buy
3,300
+74
+2% +$31.9K 0.04% 367
2025
Q3 		$1.26M Buy
3,226
+317
+11% +$132K 0.03% 389
2025
Q2 		$1.3M Buy
2,909
+81
+3% +$37.3K 0.04% 359
2025
Q1 		$1.37M Buy
2,828
+600
+27% +$280K 0.05% 319
2024
Q4 		$897K Buy
2,228
+1,054
+90% +$489K 0.01% 756
2024
Q3 		$546K Sell
1,174
-639
-35% -$307K 0.02% 445
2024
Q2 		$850K Buy
1,813
+430
+31% +$187K 0.03% 356
2024
Q1 		$578K Sell
1,383
-29
-2% -$12.3K 0.02% 420
2023
Q4 		$575K Buy
1,412
+80
+6% +$29.6K 0.02% 414
2023
Q3 		$463K Sell
1,332
-10
-0.7% -$3.5K 0.02% 426
2023
Q2 		$472K Buy
1,342
+139
+12% +$46.8K 0.02% 441
2023
Q1 		$379K Buy
+1,203
New +$361K 0.02% 474
2022
Q4 		– Sell
-1,195
Closed -$346K – 628
2022
Q3 		$346K Sell
1,195
-325
-21% -$93.5K 0.02% 456
2022
Q2 		$428K Sell
1,520
-386
-20% -$103K 0.02% 411
2022
Q1 		$497K Buy
+1,906
New +$452K 0.02% 397
2021
Q3 		– Sell
-1,187
Closed -$239K – 674
2021
Q2 		$239K Buy
1,187
+57
+5% +$11.9K 0.01% 554
2021
Q1 		$243K Buy
1,130
+49
+5% +$10.8K 0.01% 526
2020
Q4 		$255K Sell
1,081
-50
-4% -$11.5K 0.02% 465
2020
Q3 		$308K Sell
1,131
-10,424
-90% -$2.88M 0.02% 385
2020
Q2 		$3.35M Buy
11,555
+10,474
+969% +$2.84M 0.36% 57
2020
Q1 		$257K Buy
+1,081
New +$248K 0.04% 309

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Independent Advisor Alliance's VRTX Position: Q2 2026 in Review

Independent Advisor Alliance reduced its Vertex Pharmaceuticals (VRTX) stake by 10% in Q2 2026, selling an estimated $147K and leaving 2,935 shares worth $1.46M. The position accounts for 0.03% of the portfolio, ranked #352.

Independent Advisor Alliance first reported a position in VRTX in Q1 2020 and has held it in 23 quarters since. The position peaked at $3.35M in Q2 2020. 1,762 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Independent Advisor Alliance held 2,935 shares of Vertex Pharmaceuticals worth $1.46M as of Q2 2026.
  • Independent Advisor Alliance sold 332 Vertex Pharmaceuticals shares in Q2 2026, an estimated $147K.
  • Vertex Pharmaceuticals made up 0.03% of Independent Advisor Alliance's portfolio in Q2 2026, its #352 holding.
  • Independent Advisor Alliance first reported a position in Vertex Pharmaceuticals in Q1 2020 and has held it in 23 quarters since.
  • Independent Advisor Alliance's Vertex Pharmaceuticals position peaked at $3.35M in Q2 2020.
  • 1,762 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Independent Advisor Alliance's 13F filing for Q2 2026, filed 12 Aug 2026.